Thyroid and the metabolic syndrome G. Brabant Clinical and Experimental Endocrinology, MK I, University of Lübeck, Germany Definition Basic mechanisms.

Slides:



Advertisements
Similar presentations
Egyptian Perspective On Prediabetes & Diabetes
Advertisements

Body and Mind: Metabolic Syndrome and Mental Health A workshop to discuss the management of metabolic issues in people with mental illness.
1 Subclinical Hypothyroidism and the Risk of Coronary Disease and Mortality: An Individual Participant Data Analysis from Nine Prospective Cohorts N. Rodondi,

Ronald A. Codario, MD Assistant Clinical Professor of Medicine
Leptin and soluble leptin receptor and risk of clinical diabetes in African- American, Hispanic, and Asian postmenopausal women. Kathleen Brennan, MD Assistant.
A Nature Cure to High Blood Lipid Level -Hydrogen Rich Water
Syndrom of Insulinoresistance. = group of risk factors leading to early progressive (accelerated) atherosclerosis Atherosclerosis could lead to the ischaemic.
Current Management of Type 1 and Type 2 Diabetes Thomas Donner, M.D. Division of Endocrinology & Metabolism.
Metabolic & Endocrine Disease Summit Dyslipidemia and Current Guidleines for Lipid Management Thursday July 28, 2011 Orlando, FL Joyce L. Ross, MSN, CRNP,
Section 1 Review. Pulmonary disease abnormal function obstructive sleep apnea hypoventilation syndrome Nonalcoholic fatty liver disease steatosissteatohepatitiscirrhosis.
MODIFIED ADIPOKINE LEVELS IN TYPE 1 DIABETIC PATIENTS: ASSOCIATION WITH CAROTID INTIMA MEDIA THICKNESS Dilek Yazıcı, Dilek Yavuz, Önder Şirikçi, Ahmet.
Females10,121,022 (44.63% ) Males12,557,240 (55.37% ) Total 22,678,262.
What’s New in Subclinical Thyroid Disease
What Causes Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes? Charles A. Reasner, MD Professor of Medicine University of.
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Diabetes and Hypothyroidism
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Type 2 diabetes Years from diagnosis Pre-diabetes Onset Diagnosis Insulin secretion Insulin “efficiency” Ramlo-Halsted BA, Edelman SV.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
High-density lipoprotein subclasses in subjects with impaired fasting glucose Filippatos TD 1, Barkas F 1, Klouras E 1, Liontos A 1, Rizos EC 1, Gazi I.
Polycystic Ovarian Syndrome
Retinol Binding Protein-4 levels in thyroid overt and subclinical dysfunction Kokkinos Spiridon, Tiaka Elisavet, Manolakis Anastasios, Papanas Nikolaos,
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.
What is Diabetes?.
inse.ppt1 Glucose homeostasis Insulin lowers blood glucose (yes, but...) Insulin enables glucose metabolism in cells (yes, but...) Insulin exerts.
Diae121.ppt1 Diabetes mellitus Lecture from pathological physiology © Oliver Rácz, Šafárik University, Košice, Slovakia In cooperation with.
Absorptive (fed) state
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
METABOLIC Syndrome: a Global Perspective
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
The Endocannabinoid System Role in energy homeostasis and peripheral lipid and glucose metabolism.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
Diabetes National Diabetes Control Programme
Farid Saad Euro Weight Loss-2015 Frankfurt, Germany August 18 – 20, 2015.
High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Cardiometabolic Syndrome Nabil Sulaiman HOD Family and Community Medicine, Sharjah University and University of Melbourne & Dr Dhafir A. Mahmood Consultant.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
© 2013 Eli Lilly and Company Managing insulin therapy in Insulin resistance Speaker name and affiliation Prescribing information is available on the last.
Paul Zimmet & George Alberti
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.
Diabetes Mellitus Classification & Pathophysiology.
Metabolic Syndrome Dr. Hasan AYDIN. Metabolic Syndrome Clustering of cardiovascular risk factors Central obesity Diabetes Hypertension Dyslipidemia.
HYPOTHYROIDISM. INTRODUCTION  Hypothyroidism is defined as a deficiency in thyroid hormone secretion and action that produces a variety of clinical signs.
Metabolic Syndrome Endocrine Block 1 Lecture Dr. Usman Ghani.
1 Subclinical thyroid dysfunction and blood pressure: a community-based study John P. Walsh, Alexandra P. Bremner, Max K. Bulsara‡, Peter O’Leary, Peter.
Endocrine Block 1 Lecture Dr. Usman Ghani
Endocrine Block Dr. Usman Ghani
By Dr. Sumbul Fatma Clinical Chemistry Unit Department of Pathology
Obesity Dr. Sumbul Fatma.
Insulin resistance in prepubertal children
Endocrine Block 1 Lecture Dr. Usman Ghani
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Supplementary material
Effect of Metabolic Surgery on diabetes and hypertension
Screening and Monitoring
Diabetes and Bone: the model of GIO
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Obesity Eppie Habashi.
Fig. 3. Differences in the prevalence of albuminuria after comorbidity stratification. (A) Obesity defined by a body mass index ≥25 kg/m2, (B) central.
Presentation transcript:

Thyroid and the metabolic syndrome G. Brabant Clinical and Experimental Endocrinology, MK I, University of Lübeck, Germany Definition Basic mechanisms Clinical aspects Interesting cases

Definition Discuss the impact of metabolic syndrome on thyroid growth/function only focussed on thyroid impact on metabolism Definition of metabolic syndrome (WHO, IDF, NCEP-ATP-III) – insulin resistance / artherogenic dyslipidemia / hypertension – NCEP/ATP III criteria waist circumference (102 cm for men or 88 cm for women) elevated triglycerides ( 1.7mmol/l or on drug treatment for high TG) reduced HDL (cholesterol < 1.03 mmol/l in men or < 1.29 mmol/l in women or on drug treatment for reduced HDL-C) elevated fasting glucose ( 5.6 mmol/l). elevated blood pressure ( 130 mmHg systolic BP or 85 mmHg diastolic BP or on antihypertensive drug treatment for elevated BP)

Mortality and sc hypothyroidism Rodondi JAMA 2010 N = Epidemiology

Association of TSH with metabolic syndrome n = 7,270 euthyroid subjects Lee Korean J Int Med 2011

Odds ratio of meeting individual MetS criteria at baseline by thyroid function category Waring Clinical Endocrinology (2011) 76, 911–918 n = 3075 white and black subjects of the Health Ageing and Body Composition study n = 684 initially identified with metabolic syndrome

Impact of thyroid hormones on body weight Jonklaas Thyroid 2011 weight +3.3 kg healthy controls +1.3 kg Visceral obesity / body weight Asvold JCEM 2009

Thyroid hormones and energy regulation Coppola Cell Metab 5:21, 2007 UCP-2

Appetite regulation and REE in RTH and hyperthyroidism Mitchell JCI 120: 1345, 2010

Effects of thyroid hormones on hypothalamic AMPK signaling Lopez Nat Med 2010 Hyperthyroid Hypothyroid

Direct effects of T3 on BAT 0h 4h 24h UCP-1 ΔΨ 0h 24h T3T3 OCR 0h 4h 24h **

Odds ratio of meeting individual MetS criteria at baseline by thyroid function category Waring Clinical Endocrinology (2011) 76, 911–918 n = 3075 white and black subjects of the Health Ageing and Body Composition study n = 684 initially identified with metabolic syndrome Epidemiology

Regulation of FA in hyper- and hypothyroidism Klieverik Endocrinology 2009

Odds ratio of meeting individual MetS criteria at baseline by thyroid function category Waring Clinical Endocrinology (2011) 76, 911–918 n = 3075 white and black subjects of the Health Ageing and Body Composition study n = 684 initially identified with metabolic syndrome Epidemiology

Central regulation of endogenous glucose- production Klieverik PNAS 106: 5966, 2009 Schofl JCEM 87: 624, 02 rat model

Glucose homeostasis in Dio2 knock-out animals Marsili Plos One 2011

Glucose disposal rates in relation to DIO type 2 polymorphism Mentuccia Diabetes 51:880–883, 2002

GLUT expression in eu- and hyperthyreoidism Dimitriadis Horm Metab Res 37:15, 2005 Glut1 Glut3 Glut4 Dimitriadis JCEM 93:2413, 2008

Maratou EJE 2010 OGT Plasmainsulin and glucose levels in euthyroidism, sc and overt hyperthyroidism Glucose regulation diminished glycogen synthesis increased gluconeogenesis

Glucose and insulin response in eu-, sc or overt hypothyroidism Dimitriadis JCEM 91:4130, 2006 Maratou EJE 160: 785, 2009

Glucose transport and – uptake in subclin. and overt hypothyroidism Maratou EJE 160: 785, 2009 Glucose transport Hypothyroidism to euthyroidism Glut4 unchanged Glut5 increased 15x Visser JCEM 94:3497, 09

Glucose uptake and TSH

Metformin effects in T2Dm n = 828 Muscogiuri Obesity 2012

Insulin sensitivity and thyroid function in healthy subjects Roos J Clin Endocrinol Metab 92: 491–496, fT4 tertiles HOMA-IR (mU*mmol/l pmol/L 18.2 pmol/l

Insulin secretion, insulin sensitivity, metabolic clearance of insulin, glucose disposal rate in hypothyroidism with or without thyroid hormone therapy Stanicka Clin Chem Lab Med 43: 715, 2005

Effects on β-cells in lean and db/db mice Lin Br J Pharmacol 2011

Case from the National Institutes of Health A woman with type A insulin resistance secondary to a homozygous mutation of the α-subunit of the insulin receptor (IR; EMBO J : ) diagnosed as a child severely impaired IR transport to the cell surface high insulin requirements – poor metabolic control – hyperandrogenism aged 32 yrs diagnosis of PTC treated by total thyroidectomy, lymphadenectomy, radioiodine, TSH suppression with thyroxine (200 – 250 µg/d) TG slightly elevated Thyroid function and insulin resistance Skarulis J Clin Endocrinol Metab, 2010, 95(1):256–262

Thyroid function and insulin resistance Case 2

FDG-PET in a athyroid patient with type A insulin resistance Skarulis J Clin Endocrinol Metab, 2010, 95(1):256–262 T4 supp therapy Restart of T4 14 d Off T4 therapy

Effect of levothyroxine (L-T4) on metabolic parameters and laboratory tests Skarulis J Clin Endocrinol Metab, 2010, 95(1):256–262

Impact of thyroid hormones in diabetes mellitus Kadiyala 2010 Epidemiology thyroid disease / Diabetes mellitus

Autoimmune polyglandular syndrome Kahaly EJE 2009 / III

Frequency of further antibodies in 491 children with T1Dm Triolo Diabetes Care 2011 Screening for thyroid dysfunction ? Guidelines: yes for T1Dm ?? / no comment for T2Dm

Odds ratio of meeting individual MetS criteria at baseline by thyroid function category Waring Clinical Endocrinology (2011) 76, 911–918 n = 3075 white and black subjects of the Health Ageing and Body Composition study n = 684 initially identified with metabolic syndrome Epidemiology

Impact of thyroid function on blood pressure Ittermann JCEM 2012 Asvold JCEM 2007

Hypertension and thyroid dysfunction Cai Hypertension Res 2011 Longitudinal results (n= Voelzke et al 2012)

Glucose lipids Blood flow Glucose transport Glycogen synthesis Glucose transport Glucose oxidation Glucose oxidation Blood flow Glucose transport Lipolysis, NEFA Tg derived FA uptake Insulin Feeding behaviour Energy expenditure Hormonal, metabolic Signals LC-FA Glucose Insulin Leptin ghrelin WAT BAT muscle pancreas liver Multiple mechanisms for thyroid glucose / lipid interaction Gluconeogenesis Cortisol GH Tg Lipid oxidation Pathophysiology

Grueters Cell 149:671, 2012 Heart and energy expanditure